With US 181.3 Billion Global Clinical Laboratory Services Market Growth, Share, Companies, Forecast Report 2028 | Market to Grow at a CAGR of 4.9% | Vantage Market Research
June 06, 2022 10:33 ET
|
Vantage Market Research
WASHINGTON, June 06, 2022 (GLOBE NEWSWIRE) -- In recent years, the growing awareness of chronic diseases and rising cases of infectious diseases is driving the Clinical Laboratory Services Market....
Global Histology and Cytology Market to Surpass US$ 39,073.7 Million by 2028, Says Coherent Market Insights (CMI)
August 20, 2021 09:00 ET
|
CMI
SEATTLE, Aug. 20, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global histology and cytology market is estimated to be valued at US$ 16,253.0 million in 2021 and is expected...
Insights on the Histology and Cytology Global Market to 2027 - Featuring Danaher, Hologic and PerkinElmer Among Others
May 28, 2021 07:38 ET
|
Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Histology and Cytology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis,...
Global IVD Market Report 2021 with COVID-19 Impacts (Q3 2020 to Q1 2021)
May 04, 2021 05:13 ET
|
Research and Markets
Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "2021 IVD Market Update and COVID-19 Impact" report has been added to ResearchAndMarkets.com's offering. This report, 2021 IVD Market Update and...
Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation
April 25, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Pennsylvania and Connecticut Labs Both Receive Accreditation PARSIPPANY, NJ, April 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has...
Clinical Laboratory Services Market size to exceed $342bn by 2024: Global Market Insights Inc.
November 01, 2016 06:00 ET
|
Global Market Insights
Ocean View, Delaware, Nov. 01, 2016 (GLOBE NEWSWIRE) -- Clinical Laboratory Services Market size was USD 196.9 billion in 2015, with 6.4% CAGR estimation from 2016 to 2024; as per a new research...
Atossa Genetics Launches ForeCYTE Breast Health Test(SM) for Breast Cancer Risk Assessment
December 06, 2011 08:30 ET
|
Atossa Genetics
SEATTLE, WA--(Marketwire - Dec 6, 2011) - Atossa Genetics, Inc., a health care company developing and commercializing a comprehensive set of innovative, proprietary breast health evaluation...
Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement
October 01, 2010 09:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...